trending Market Intelligence /marketintelligence/en/news-insights/trending/wdfuBIKqPXtUnzUM5aLdvQ2 content esgSubNav
In This List

J&J recommends shareholders reject Peer & Peri's mini-tender offer

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


J&J recommends shareholders reject Peer & Peri's mini-tender offer

Johnson & Johnson advised its shareholders to reject a mini-tender offer by Peer & Peri LLC as it was priced about 22.6% below-market.

Peer & Peri offered to buy up to 30,000 of the company's common shares, or about a 0.001% stake, for $98.50 per share in cash. J&J shares closed at $127.27 per share on Dec. 28, 2018, the last closing before the offer was launched.

New Brunswick, N.J.-based Johnson & Johnson, the world's largest pharmaceutical company, recommended that shareholders who have not responded to the offer to take no action, and those who tendered shares to withdraw them before the offer expires at 5 p.m. ET on Jan. 31.

Mini-tender offers involve the acquisition of less than 5% of a company's stock, allowing the buyer to avoid certain disclosure and procedural requirements of the U.S. SEC.